Older children with newly diagnosed type 1 diabetes who received intensive diabetes management with automated insulin delivery had no difference in pancreatic C-peptide levels compared with standard care, according to study data.
“Achieving excellent glycemic control soon after diagnosis of type 1 diabetes was unsuccessful in preventing the progressive loss of insulin production by the
Once-daily oral verapamil may help preserve stimulated C-peptide secretion for children and adolescents with type 1 diabetes, according to a study published in JAMA.
In findings from a randomized, double-blind, placebo-controlled trial, people aged 7 to 17 years with newly diagnosed type 1 diabetes had a higher C-peptide area under the curve at 52 weeks if they received oral verapamil daily vs.
A lower A1C and fewer episodes of high and low blood sugar are some of the potential perks for people with type 2 diabetes who are on insulin. Read more about the research here.